These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26542656)

  • 1. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Levine BD; Baggish AL; Kovacs RJ; Link MS; Maron MS; Mitchell JH
    J Am Coll Cardiol; 2015 Dec; 66(21):2350-2355. PubMed ID: 26542656
    [No Abstract]   [Full Text] [Related]  

  • 2. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Gerhard-Herman MD; Gornik HL; Barrett C; Barshes NR; Corriere MA; Drachman DE; Fleisher LA; Fowkes FG; Hamburg NM; Kinlay S; Lookstein R; Misra S; Mureebe L; Olin JW; Patel RA; Regensteiner JG; Schanzer A; Shishehbor MH; Stewart KJ; Treat-Jacobson D; Walsh ME
    Circulation; 2017 Mar; 135(12):e726-e779. PubMed ID: 27840333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Halperin JL; Levine GN; Al-Khatib SM; Birtcher KK; Bozkurt B; Brindis RG; Cigarroa JE; Curtis LH; Fleisher LA; Gentile F; Gidding S; Hlatky MA; Ikonomidis J; Joglar J; Pressler SJ; Wijeysundera DN
    Circulation; 2016 Apr; 133(14):1426-8. PubMed ID: 26399660
    [No Abstract]   [Full Text] [Related]  

  • 4. AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and US Department of Health and Human Services.
    Arnett DK; Goodman RA; Halperin JL; Anderson JL; Parekh AK; Zoghbi WA
    Circulation; 2014 Oct; 130(18):1662-7. PubMed ID: 25212466
    [No Abstract]   [Full Text] [Related]  

  • 5. 2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.
    ; Bozkurt B; Das SR; Addison D; Gupta A; Jneid H; Khan SS; Koromia GA; Kulkarni PA; LaPoint K; Lewis EF; Michos ED; Peterson PN; Turagam MK; Wang TY; Yancy CW
    J Am Coll Cardiol; 2022 Jul; 80(4):388-465. PubMed ID: 35753858
    [No Abstract]   [Full Text] [Related]  

  • 6. Participation in Competitive Sports by Patients With Congenital Heart Disease: AHA/ACC and EAPC/ESC/AEPC Guidelines Comparison.
    Shibbani K; Abdulkarim A; Budts W; Roos-Hesselink J; Müller J; Shafer K; Porayette P; Zaidi A; Kreutzer J; Alsaied T
    J Am Coll Cardiol; 2024 Feb; 83(7):772-782. PubMed ID: 38355248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association.
    Fleg JL; Forman DE; Berra K; Bittner V; Blumenthal JA; Chen MA; Cheng S; Kitzman DW; Maurer MS; Rich MW; Shen WK; Williams MA; Zieman SJ;
    Circulation; 2013 Nov; 128(22):2422-46. PubMed ID: 24166575
    [No Abstract]   [Full Text] [Related]  

  • 8. Environmental Exposures and Pediatric Cardiology: A Scientific Statement From the American Heart Association.
    Zachariah JP; Jone PN; Agbaje AO; Ryan HH; Trasande L; Perng W; Farzan SF;
    Circulation; 2024 May; 149(20):e1165-e1175. PubMed ID: 38618723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What's new in sports cardiology? Hot topics from "Sport and Heart," First International Congress in Sports Cardiology.
    Fusco L; Sciarra L
    Clin Cardiol; 2023 Sep; 46(9):1013-1014. PubMed ID: 37226865
    [No Abstract]   [Full Text] [Related]  

  • 10. Ms-represented: strategies to increase female representation in sports cardiology research.
    Mitchell A; Janssens K; Howden EJ; La Gerche A; Orchard JJ
    Br J Sports Med; 2024 Feb; 58(3):122-124. PubMed ID: 37903547
    [No Abstract]   [Full Text] [Related]  

  • 11. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Zipes DP; Link MS; Ackerman MJ; Kovacs RJ; Myerburg RJ; Estes NAM
    J Am Coll Cardiol; 2015 Dec; 66(21):2412-2423. PubMed ID: 26542670
    [No Abstract]   [Full Text] [Related]  

  • 12. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Udelson JE; Bonow RO; Nishimura RA; Ackerman MJ; Estes NAM; Cooper LT; Link MS; Maron MS
    J Am Coll Cardiol; 2015 Dec; 66(21):2362-2371. PubMed ID: 26542657
    [No Abstract]   [Full Text] [Related]  

  • 13. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Link MS; Estes NAM; Maron BJ
    J Am Coll Cardiol; 2015 Dec; 66(21):2439-2443. PubMed ID: 26542669
    [No Abstract]   [Full Text] [Related]  

  • 14. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Braverman AC; Harris KM; Kovacs RJ; Maron BJ
    J Am Coll Cardiol; 2015 Dec; 66(21):2398-2405. PubMed ID: 26542664
    [No Abstract]   [Full Text] [Related]  

  • 15. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Levine BD; Washington RL; Baggish AL; Kovacs RJ; Maron MS
    J Am Coll Cardiol; 2015 Dec; 66(21):2356-2361. PubMed ID: 26542659
    [No Abstract]   [Full Text] [Related]  

  • 16. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology.
    Black HR; Sica D; Ferdinand K; White WB
    J Am Coll Cardiol; 2015 Dec; 66(21):2393-2397. PubMed ID: 26542658
    [No Abstract]   [Full Text] [Related]  

  • 17. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Van Hare GF; Ackerman MJ; Evangelista JK; Kovacs RJ; Myerburg RJ; Shafer KM; Warnes CA; Washington RL
    J Am Coll Cardiol; 2015 Dec; 66(21):2372-2384. PubMed ID: 26542660
    [No Abstract]   [Full Text] [Related]  

  • 18. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement from the American Heart Association and American College of Cardiology.
    Thompson PD; Myerburg RJ; Levine BD; Udelson JE; Kovacs RJ
    J Am Coll Cardiol; 2015 Dec; 66(21):2406-2411. PubMed ID: 26542666
    [No Abstract]   [Full Text] [Related]  

  • 19. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Bonow RO; Nishimura RA; Thompson PD; Udelson JE
    J Am Coll Cardiol; 2015 Dec; 66(21):2385-2392. PubMed ID: 26542667
    [No Abstract]   [Full Text] [Related]  

  • 20. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Ackerman MJ; Zipes DP; Kovacs RJ; Maron BJ
    J Am Coll Cardiol; 2015 Dec; 66(21):2424-2428. PubMed ID: 26542662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.